• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ARMADA 35 PTA CATHETER; PERIPHERAL DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ARMADA 35 PTA CATHETER; PERIPHERAL DILATATION CATHETER Back to Search Results
Model Number B1070-040
Device Problems Difficult to Remove (1528); Material Rupture (1546); Material Separation (1562); Difficult to Advance (2920)
Patient Problems Hemorrhage/Bleeding (1888); Foreign Body In Patient (2687)
Event Date 06/04/2020
Event Type  Injury  
Manufacturer Narrative
Product performance engineering reviewed the incident information; however, the product was not returned to abbott vascular for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the review of similar incident(s) there is no indication of a lot specific product quality issue.The device was prepped prior to use with no issue/ leak noted, which would suggest that the device was not damaged prior to use.The investigation determined the reported difficulties appear to be related to operational circumstances of the procedure.Based on the reported information, it is likely that during advancement through the heavily calcified lesion, the balloon surface became damaged and/or compromised resulting in the reported balloon rupture.The balloon rupture did not properly refold causing the difficulty to remove from the introducer sheath.Manipulation against resistance resulted in the balloon separation.The reported patient effect of hemorrhage is listed in the armada 35 percutaneous transluminal angioplasty catheter instructions for use, as a known patient effect of the procedure.A conclusive cause for the reported patient effect(s), of hemorrhage and the relationship to the product, if any, cannot be determined.However, the reported treatments appear to be related to the operational context of the procedure as a surgical cut down was performed to access the artery and a suture was used to close the access site.There is no indication of a product quality issue with respect to manufacture, design or labeling.The additional armada device referenced is being filed under a separate medwatch report number.
 
Event Description
It was reported that the procedure was to treat a primitive iliac artery using retrograde approach.There was heavy calcification in the femoral and iliac arteries.A 7.0x40 mm armada 35 percutaneous transluminal angioplasty (pta) catheter was inflated at 12 atmospheres and ruptured.During removal, there was resistance, the introducer needed to be removed, and the balloon tore into several pieces.A second, same size, armada 35 pta catheter was used and had the same issue and ruptured between 10-12 atm.Another unspecified balloon was used to complete the procedure; however, the patient had bleeding during removal of the introducer and there is a possibility that balloon material was left in the anatomy.A surgical cut down was performed to access the artery and a suture was used to close the access site.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARMADA 35 PTA CATHETER
Type of Device
PERIPHERAL DILATATION CATHETER
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR COSTA RICA, REG # 3009564766
52 calle 3 b31 coyol free zone
el coyol alajuela
CS  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key10260564
MDR Text Key198531107
Report Number2024168-2020-05675
Device Sequence Number1
Product Code LIT
UDI-Device Identifier08717648154782
UDI-Public08717648154782
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K111899
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 07/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/10/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2023
Device Model NumberB1070-040
Device Catalogue NumberB1070-040
Device Lot Number00226G1
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/19/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/26/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-